Safety and efficacy of (+)-epicatechin in subjects with Friedreich's ataxia: A phase II, open-label, prospective study

Muhammad Yasir Qureshi, Marc C. Patterson, Vicki Clark, Jonathan N. Johnson, Margaret A. Moutvic, Sherilyn W. Driscoll, Jennifer L. Kemppainen, John Huston, Jeff R. Anderson, Andrew D. Badley, Peter J. Tebben, Philip Wackel, Devin Oglesbee, James Glockner, George Schreiner, Sundeep Dugar, Jillienne C. Touchette, Ralitza H. Gavrilova

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of (+)-epicatechin in subjects with Friedreich's ataxia: A phase II, open-label, prospective study'. Together they form a unique fingerprint.

Medicine & Life Sciences